Raymond H. Cypess, DVM, Ph.D.
Raymond is Chairman and CEO of ATCC and ATCC Global. In this role, he has demonstrated the ability to apply business acumen, fiscal responsibility, and innovative approaches to the management of a non-profit/for-profit corporate structure. He holds a DVM from the University of Illinois and a Ph.D. in parasitology from the University of North Carolina.
Prior to joining ATCC, Raymond was Dean of the College of Graduate Health Sciences, Professor of Microbiology and Immunology and Comparative Medicine, and Vice Provost for Research and Research Training, at the University of Tennessee, Memphis. He was awarded the University of Tennessee Memphis College of Medicine Outstanding Teacher Award for 1989–1993. Raymond has been an Associate Professor of Epidemiology and Microbiology at the University of Pittsburgh School of Public Health and Professor and Chairman at the New York State College of Veterinary Medicine.
Raymond participated on the National Institute of Allergy and Infectious Diseases (NIAID) scientific review boards and various NIH Study Sections and served on several editorial boards. He is the author of more than 80 chapters, reviews, and journal articles, a fellow in the Infectious Disease Society, and a member of the American Epidemiology Society. At ATCC, he has served as principal investigator on numerous grants and contracts, including the Malaria Research and Reference Reagent Resource Center (MR4) and the Biodefense and Emerging Infections Resources repository (BEI Resources) from NIAID. He has served on boards for the New York Stock Exchange and NASDAQ corporations as well as Director and Treasurer of the Virginia Biotechnology Authority.
Ralph Koch, CPA
Senior Vice President, Finance and Administration and Chief Financial Officer
Ralph is Senior Vice President of Finance and Administration and Chief Financial Officer for ATCC. In this role, he leads and coordinates the financial management of all continuing operations and new programs. He also administers all corporate-related administrative activities, IT, and Data Management functions while working collaboratively with the senior leadership team in the diversification of corporate business interests.
Prior to joining ATCC, Ralph fostered continuous process improvements in finance, contracts, and operations as well as developed business strategies and capitalization plans at high-growth aerospace and technology companies. He served as Vice President and Chief Financial Officer at Aurora Flight Sciences Corporation, Regal Works, Inc., CardSystems Solutions, Inc., and Information Management Consultants. Prior to these roles, Ralph was an audit partner at KPMG in the Washington, D.C., practice area.
Ralph is a certified public accountant and holds a bachelor’s degree in Business Administration from George Mason University.
Scott A. Siegel, Ph.D.
Vice President, Corporate Development and Chief Business Officer
Scott is Vice President of Corporate Development and Chief Business Officer for ATCC. In this role, he leads ATCC’s overall growth and business development strategy, including efforts to identify and negotiate partnership and M&A opportunities that enhance and expand ATCC’s products and services portfolio.
Scott brings more than 25 years’ experience as a business and scientific leader in the biotech and pharma industries to this role. He joined ATCC from the non-profit Institute of Life Science Entrepreneurship, where he was co-founder and Vice President of Business Development for this New Jersey-based life sciences incubator and accelerator.
He founded Milestone Life Sciences, a business development and strategic advisory firm, and previously held senior business leadership roles at Ezose Sciences, Redpoint Bio, and Johnson & Johnson.
Scott earned his Ph.D. in Biochemistry from SUNY Downstate Medical Center, completed postdoctoral studies in Pharmacology at Yale University, and spent the early part of his career as an R&D leader in fast moving biotech and start-up companies, including Centocor and Phytera. He has more than 60 publications and patents and contributed to the development of three launched products, including as co-inventor of Remicade®, the blockbuster anti-TNF therapy used worldwide in the treatment of more than two million patients with autoimmune disorders. Scott previously served as Adjunct Associate Professor of Microbiology at the University of Pennsylvania and more recently as Lecturer in the MBA program at the Wharton School.
Mindy Goldsborough, Ph.D.
Chief Science and Technology Officer
Vice President and General Manager, ATCC Cell Systems
As the Chief Science and Technology Officer for ATCC, Mindy works across ATCC’s business units and functions to develop and implement the scientific and technology strategy in support of organizational goals. Additionally, she oversees the ATCC Cell Systems (ACS) business unit located within Maryland’s High Technology Corridor in Gaithersburg, MD. ACS is the innovative cell biology product and technology development arm of ATCC. Its current focus is in areas of functional cell biology supporting basic and translational research.
Prior to ATCC, Mindy was Director of R&D for BD Biosciences’ Advanced Bioprocessing group. Her previous work includes senior R&D roles at BD Biosciences’ Bioimaging business (formerly Atto Biosciences) and Life Technologies, where she led R&D efforts in DNA-based diagnostics, stem cell biology, forensics, and nucleic acid purification. Mindy has more than 25 years of product and technology development expertise in cell and molecular biology. Several products that she helped develop during her career are still market standards today.
Mindy earned her Ph.D. in Genetics from The George Washington University, and completed her dissertation research and post-doctoral work at The National Institutes of Health, National Cancer Institute.
Joseph Leonelli, Ph.D.
Vice President, ATCC Federal Solutions
Joe is Vice President of ATCC Federal Solutions (AFS). In this role, he is responsible for the overall strategy, management and growth of AFS programs, which include products and services for emerging infectious disease, biodefense, medical countermeasures, and global health security.
Prior to joining ATCC, Joe was Vice President for National Security Systems and Solutions for Engility, where he managed three business units providing systems and software engineering to DOD, DOJ, and Intelligence Community customers. He held leadership positions at various entities within Raytheon, Applied Signal Technology, Inc., General Dynamics, Battelle, and SRI International.
Joe is active with the National Defense Industrial Association (NDIA), Association of the U.S. Army (AUSA), Armed Forces Communications Electronics Association (AFCEA), and Advanced Technical Intelligence Association (ATIA). Joe earned his Ph.D. in Inorganic Chemistry from Indiana University.
Shou C. Wong, Ph.D.
Senior Director, ATCC Microbiology Systems
Shou is Senior Director of ATCC Microbiology Systems (AMS). In this role, he is responsible for the overall strategy, management, and growth of AMS.
Shou joined ATCC from the Dow Chemical Company, where he was Advanced Diagnostics Platform Technology leader for Dow’s Microbial Control business unit. In this role, he developed Dow’s innovation pipeline for advanced diagnostic applications by leading the identification, analysis, development, and commercialization of new diagnostic sensors and assays for detecting harmful microorganisms in water, energy, and hygiene sectors. Shou’s previous work includes R&D, business development, technology scouting and technical sales roles at Merck KGaA/EMD Millipore and Thermo Fisher/Life Technologies.
Shou earned his Ph.D. in Molecular Genetics and Microbiology from Georgia State University, and was a post-doctoral fellow at Washington University Medical School and later a visiting fellow at Harvard Medical School.
Maryellen de Mars, Ph.D.
Senior Director, Standards Resource Center
Maryellen is Senior Director of ATCC’s Standards Resource Center (SRC), a business unit focused on standards and related services. The SRC includes the Central Acquisition Unit (CAU), the Standards Development Organization (SDO), Services and Metrology R&D.
Prior to joining ATCC, Maryellen was Chief Operating Officer and Vice President of Clinical Operations at USDS, Inc., an independent third party evaluating the performance of molecular diagnostic tests to support regulatory, reimbursement, and adoption efforts. She also served as Director of Clinical Biomarkers at Critical Path Institute (C-Path), leading collaborative efforts to evaluate and improve the use of clinical biomarkers and optimize the pathway for development of companion diagnostics. She served as Executive Director of Genomics Services and Director of Biorepository at Gene Logic, Inc., and led business development and marketing efforts at Life Technologies, Inc.
She earned her Ph.D. in Virology from the University of Texas, and completed postdoctoral training in transcriptional regulation at The Johns Hopkins University.
James J. Kramer, Ph.D.
Vice President, Operations
Jim is Vice President of Operations for ATCC. In this role, he oversees ATCC’s manufacturing, inventory/repository, supply chain, facilities, Quality Control/Quality Assurance, regulatory compliance, and distribution of ATCC’s biological products worldwide.
Prior to joining ATCC, Jim acquired significant subject matter and operational expertise in the fields of biomanufacturing, supply chain management, regulated biologics, commercial operations, quality systems, and GMP-cell banking. He was vice president at several global bioscience, medical device, and biopharmaceutical organizations including Immucor, Inc., Bioreliance, Talecris Biotherapeutics, and Serologicals Corporation, and held various positions at Ortho-Clinical Diagnostics, Inc., a Johnson & Johnson Company.
Jim earned his Ph.D. in Biochemistry from the University of Medicine and Dentistry of New Jersey and completed postdoctoral training in Protein Biochemistry at The University of North Carolina at Chapel Hill.
Teri Sellars, SPHR, SHRM-SCP
Senior Director, Human Resources
Teri is Senior Director of Human Resources for ATCC. In this role, she is responsible for Human Capital strategy and for directing all of the people functions of the organization, including talent acquisition, development, engagement, and management; total rewards programs; HR regulatory compliance; talent data management; and leadership development.
Teri joined ATCC from Analytic Services, Inc. (ANSER), a non-profit corporation providing expertise to public sector clients in the arenas of national and homeland security. Prior to ANSER, Teri served in a number of HR leadership/business partner roles for small companies and for divisions of larger organizations, including Convergys Corporation, Freddie Mac, Wireless Facilities, Inc., and WCI Communities. Teri has years of experience in transforming the HR function, mergers, acquisitions and integrations, and standing up HR departments.
Teri received her bachelor’s degree in French Business Studies from the University of Illinois at Chicago and completed a year of study at the University of Paris - La Sorbonne in Paris, France. Teri holds her Senior Professional in Human Resources certification as well as her SHRM-Senior Certified Professional, and has served on the Board of the Dulles SHRM chapter.
Keith Jolliff, Ph.D.
Senior Director, Sales and Marketing
Keith is Senior Director of Sales and Marketing for ATCC. In this role, he is responsible for all customer facing functions including tactical marketing, the ATCC website, the domestic and international sales organizations, technical support, and order entry.
Keith joined ATCC as Director of Sales Operations, bringing more than 20 years of life science industry experience to the organization. Prior to ATCC, he was Director of Digital Marketing for QIAGEN, where he was responsible for developing, shaping, and managing its digital footprint across multiple channels. His previous work includes senior sales and marketing leadership positions at Thermo Fisher Scientific, Sigma-Aldrich Corporation, and Promega Corporation.
Keith earned his Ph.D. in Molecular Biology from The Ohio State University and completed his post-doctoral work at Washington University Medical School.
Director, Corporate Communications and Public Affairs
Melissa is Director of Corporate Communications and Public Affairs for ATCC. In this role, she serves as strategist for ATCC’s global branding, public relations, and internal communications programs. Additionally, she provides executive communications expertise to business and functional partners.
Melissa has more than 15 years of experience as a communications professional. She joined ATCC from Raytheon Space and Airborne Systems, where she was Senior Manager of Communications Strategy and Operations for the $6.1 billion defense technology leader.
Prior to the Raytheon acquisition in 2011, Melissa was Director of Marketing Communications for Applied Signal Technology, Inc. (AST), where she built the department from the ground up, providing advertising, branding, marketing, public relations, executive and employee communications, event management, and creative services support. Prior to AST, she was Senior Marketing Communications Specialist for General Dynamics Advanced Information Systems. She also served as a Program Management Specialist for the U.S. Coast Guard’s Deepwater Program, supporting the Program Executive Officer with communications and public affairs activities.
Melissa earned a bachelor’s degree in Advertising and Marketing Communications from the Fashion Institute of Technology, State University of New York.